Abingworth — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)in
Co-investorsvenBio PartnersvenBio Global Strategic
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Launch Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.